SCHEMBL2070916

SCHEMBL2070916

O=C(N1CCCc2ccccc21)N1C2C=C(c3cccc4ncccc34)CC1CC2

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 7/20 0.45
LMNA P02545 3/20 0.40
RECQL P46063 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
HTT P42858 2/20 0.39
GAA P10253 2/20 0.39
POLB P06746 3/20 0.38
HSD17B10 Q99714 1/20 0.38
ALDH1A1 P00352 2/20 0.37
SMO Q99835 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 1/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070915 1.00 HSD11B1 (0.45) HSD11B1LMNARECQLSMN1; SMN2HTT
SCHEMBL2070282 0.87 HSD11B1 (0.45) HSD11B1LMNARECQLSMN1; SMN2POLB
SCHEMBL2070280 0.87 HSD11B1 (0.45) HSD11B1LMNARECQLSMN1; SMN2POLB
SCHEMBL2070481 0.87 HSD11B1 (0.47) HSD11B1SMN1; SMN2GAAPOLBHSD17B10
SCHEMBL2070483 0.87 HSD11B1 (0.47) HSD11B1SMN1; SMN2GAAPOLBHSD17B10
SCHEMBL2072681 0.86 HSD11B1 (0.43) HSD11B1LMNASMN1; SMN2HTTGAA
SCHEMBL2072678 0.86 HSD11B1 (0.43) HSD11B1LMNASMN1; SMN2HTTGAA
SCHEMBL2070918 0.84 HSD11B1 (0.45) HSD11B1GAAALDH1A1KDM4EMAPT
SCHEMBL2070921 0.84 HSD11B1 (0.45) HSD11B1GAAALDH1A1KDM4EMAPT
SCHEMBL2071567 0.84 HSD11B1 (0.45) HSD11B1SMN1; SMN2HTTPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897773-B2 Urea derivatives of tropane, their preparation and their therapeutic application SANOFI-AVENTIS (FR) 2011-03-01 US disclosed
US-20100324084-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2010-12-23 US disclosed
EP-2046791-B1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2010-03-24 EP disclosed
US-20090170894-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2009-07-02 US disclosed
EP-2046791-A2 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION Sanofi-Aventis (FR) 2009-04-15 EP disclosed
WO-2008000951-A2 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2008-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170894-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HSD11B1, ADRA1D, HSD17B1 HSD11B1 1/4885LMNA 1328/4885RECQL 1074/4885
US-20100324084-A1 UREA DERIVATIVES OF TROPANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HSD11B1, ADRA1D, HSD17B1 HSD11B1 1/4885LMNA 1328/4885RECQL 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.